Browse By Model Organism Result Page of OvirusTdb

The total number of records retrieved from this search are 67. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_3738Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell line22RV1NANANANANABalb/c-rag and gamma negative xenograft for 22Rv1 (2.0E+6)1.0E+7 pfuNA Regression in tumor volume to 0.4 cm after day 80IntratumoralNANANA29696636
OV_3739Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell line22RV1NANANANANABalb/c-rag and gamma negative xenograft for 22Rv1 (2.0E+6)1.0E+7 pfuNA Complete regression in tumor after day 80IntravenousNANANA29696636
OV_3740Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell lineVCaPNANANANANABalb/c-rag and gamma negative xenograft for VCap (2.0E+6)1.0E+7 pfuNA Regression in tumor volume to 0.3 cm after day 80IntratumoralNANANA29696636
OV_3771Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKYesNoNoType culture collection of chinaHuman pancreatic cancer cell lineSW1990NANANANANABalb/c nude mice xenograft for SW19902.0E+7 pfuNA Significant reduction in tumor volume after 56 daysIntratumoralVirus induce apoptosis in cancer cellNANA30365143
OV_3772Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKNoVirus in combination with gemcitabine (50mg/kg)NoType culture collection of chinaHuman pancreatic cancer cell lineSW1990NANANANANABalb/c nude mice xenograft for SW19902.0E+7 pfuNA Significant reduction in tumor volume to below 500mm after 56 daysIntratumoralVirus induce apoptosis in cancer cellNANA30365143
OV_3773Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKYesNoNoType culture collection of chinaHuman pancreatic cancer cell lineSW1990/Gemcitabine resistantNANANANANABalb/c nude mice xenograft for SW19902.0E+7 pfuNA Significant reduction in tumor volume after 56 daysIntratumoralVirus induce apoptosis in cancer cellNANA30365143
OV_3774Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKNoVirus in combination with gemcitabine (50mg/kg)NoType culture collection of chinaHuman pancreatic cancer cell lineSW1990/Gemcitabine resistantNANANANANABalb/c nude mice xenograft for SW19902.0E+7 pfuNA Significant reduction in tumor volume to below 300mm after 56 daysIntratumoralVirus induce apoptosis in cancer cellNANA30365143
OV_4083AdenovirusAdenovirus ZD55DNAAdenoviridaeVirus encoded with drosophila dNK geneNoVirus in combination with drug DFDC(10mg/kg)NoShanghai cell collectionNANANANANANANABALB/c nude mice xenograft for MCF7 (1.0E+7)1.0E+9 pfuNA Virus and drug prolongs the mice survival and reduction in tumor volume to 1000mm compared to control 3000mm after 60 daysIntratumoralVirus induced apoptosis in cancer cellNANA26203222
OV_4204AdenovirusAd-CXCR4-DAL1DNAAdenoviridaeVirus expressing DAL-1 gene under promoter CXXR4YesNoNoNANANANANANANANABALB/c nude mice subcutaneously xenograft for A549 cell (2.0E+6)1.0E+9 pfu, every other day for 3 timesNA Reduction in tumor volume to 1.5 centimeter cube after 28 days compared to control 7 centimeter cubeIntratumoralVirus induce apoptosis process leads to cancer cell deathNANA26280082
OV_4225Sindbis virusAR339RNATogaviridaeNoneYesNoNoNANANANANANANANABALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)1.0E+6 pfuNA Complete reduction in tumor volume after 21 days in mice 1 and increase in PFS above 200 days compared to control 75 daysIntratumoralVirus induce apoptosis process leads to cancer cell deathIncreased expression of Bcl-2 and Bcl-xL expressionNA26298056
OV_4226Sindbis virusAR339RNATogaviridaeNoneYesNoNoNANANANANANANANABALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)1.0E+6 pfuNA Complete reduction in tumor volume after 42 days in mice 2 and increase in PFS above 200 days compared to control 75 daysIntratumoralVirus induce apoptosis process leads to cancer cell deathIncreased expression of Bcl-2 and Bcl-xL expressionNA26298056
OV_4227Sindbis virusAR339RNATogaviridaeNoneYesNoNoNANANANANANANANABALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)1.0E+6 pfuNA Complete reduction in tumor volume after 49 days in mice 3 and increase in PFS above 200 days compared to control 75 daysIntratumoralVirus induce apoptosis process leads to cancer cell deathIncreased expression of Bcl-2 and Bcl-xL expressionNA26298056
OV_4228Sindbis virusAR339RNATogaviridaeNoneYesNoNoNANANANANANANANABALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)1.0E+6 pfuNA Complete reduction in tumor volume after 56 days in mice 4 and increase in PFS above 200 days compared to control 75 daysIntratumoralVirus induce apoptosis process leads to cancer cell deathIncreased expression of Bcl-2 and Bcl-xL expressionNA26298056
OV_4229Sindbis virusAR339RNATogaviridaeNoneYesNoNoNANANANANANANANABALB/c AnNcrj-nu/nu female mice xenograft for IMR-32 (1.0E+6)1.0E+6 pfuNA Reduction in tumor volume to 100 cubic millimetet after 70 days in mice 1 and increase in PFS above 200 days from 150 days to controlIntratumoralVirus induce apoptosis process leads to cancer cell deathIncreased expression of Bcl-2 and Bcl-xL expressionNA26298056
OV_4230Sindbis virusAR339RNATogaviridaeNoneYesNoNoNANANANANANANANABALB/c AnNcrj-nu/nu female mice xenograft for IMR-32 (1.0E+6)1.0E+6 pfuNA Complete reduction in tumor volume after 49 days in mice 2 and increase in PFS above 200 days from 150 days to controlIntratumoralVirus induce apoptosis process leads to cancer cell deathIncreased expression of Bcl-2 and Bcl-xL expressionNA26298056
OV_4231Sindbis virusAR339RNATogaviridaeNoneYesNoNoNANANANANANANANABALB/c AnNcrj-nu/nu female mice xenograft for IMR-32 (1.0E+6)1.0E+6 pfuNA Complete reduction in tumor volume after 49 days in mice 3 and increase in PFS above 200 days from 150 days to controlIntratumoralVirus induce apoptosis process leads to cancer cell deathIncreased expression of Bcl-2 and Bcl-xL expressionNA26298056
OV_4232Sindbis virusAR339RNATogaviridaeNoneYesNoNoNANANANANANANANABALB/c AnNcrj-nu/nu female mice xenograft for IMR-32 (1.0E+6)1.0E+6 pfuNA Complete reduction in tumor volume after 56 days in mice 4 and increase in PFS above 200 days from 150 days to controlIntratumoralVirus induce apoptosis process leads to cancer cell deathIncreased expression of Bcl-2 and Bcl-xL expressionNA26298056
OV_4233Sindbis virusAR339RNATogaviridaeNoneYesNoNoNANANANANANANANABALB/c AnNcrj-nu/nu female mice xenograft for IMR-32 (1.0E+6)1.0E+6 pfuNA Complete reduction in tumor volume after 56 days in mice 5 and increase in PFS above 200 days from 150 days to controlIntratumoralVirus induce apoptosis process leads to cancer cell deathIncreased expression of Bcl-2 and Bcl-xL expressionNA26298056
OV_4234Sindbis virusAR339RNATogaviridaeNoneYesNoNoNANANANANANANANABALB/c AnNcrj-nu/nu female mice xenograft for IMR-32 (1.0E+6)1.0E+6 pfuNA Complete reduction in tumor volume after 70 days in mice 6 and increase in PFS above 200 days from 150 days to controlIntratumoralVirus induce apoptosis process leads to cancer cell deathIncreased expression of Bcl-2 and Bcl-xL expressionNA26298056
OV_4235Sindbis virusAR339RNATogaviridaeNoneYesNoNoNANANANANANANANABALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)1.0E+6 pfuNA Reduction in tumor volume to 1000 cubic millimeter in mice 1 after 56 daysIntravenousVirus induce apoptosis process leads to cancer cell deathIncreased expression of Bcl-2 and Bcl-xL expressionNA26298056
OV_4236Sindbis virusAR339RNATogaviridaeNoneYesNoNoNANANANANANANANABALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)1.0E+6 pfuNA Complete reduction in tumor volume after 28 days in mice 2IntravenousVirus induce apoptosis process leads to cancer cell deathIncreased expression of Bcl-2 and Bcl-xL expressionNA26298056
OV_4237Sindbis virusAR339RNATogaviridaeNoneYesNoNoNANANANANANANANABALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)1.0E+6 pfuNA Complete reduction in tumor volume after 28 days in mice 3IntravenousVirus induce apoptosis process leads to cancer cell deathIncreased expression of Bcl-2 and Bcl-xL expressionNA26298056
OV_4238Sindbis virusAR339RNATogaviridaeNoneYesNoNoNANANANANANANANABALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)1.0E+6 pfuNA Complete reduction in tumor volume after 28 days in mice 4IntravenousVirus induce apoptosis process leads to cancer cell deathIncreased expression of Bcl-2 and Bcl-xL expressionNA26298056
OV_4239Sindbis virusAR339RNATogaviridaeNoneYesNoNoNANANANANANANANABALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)1.0E+6 pfuNA Complete reduction in tumor volume after 48 days in mice 5IntravenousVirus induce apoptosis process leads to cancer cell deathIncreased expression of Bcl-2 and Bcl-xL expressionNA26298056
OV_4240Sindbis virusAR339RNATogaviridaeNoneYesNoNoNANANANANANANANABALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)1.0E+6 pfuNA Complete reduction in tumor volume after 56 days in mice 6IntravenousVirus induce apoptosis process leads to cancer cell deathIncreased expression of Bcl-2 and Bcl-xL expressionNA26298056
OV_4241Sindbis virusAR339RNATogaviridaeNoneYesNoNoNANANANANANANANABALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)1.0E+6 pfuNA Complete reduction in tumor volume after 56 days in mice 7IntravenousVirus induce apoptosis process leads to cancer cell deathIncreased expression of Bcl-2 and Bcl-xL expressionNA26298056
OV_4364AlphavirusM1RNATogaviridaeNoneNoVirus in combination with 8-CPT-cAMP (20mg/kg/day)NoNANANANANANANANABALB/c nude mice subcutaneous xenograft for HCT-116 (5.0E+6)3.0E+7 pfuNA Reduction in tumor volume to below 0.4 cubic centimeter after 22 days compared to control 1.2 cubic centimeterIntravenousActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4365AlphavirusM1RNATogaviridaeNoneNoVirus in combination with 8-CPT-cAMP (20mg/kg/day)NoNANANANANANANANABALB/c nude mice subcutaneous xenograft for Hep3B (5.0E+6)5.0E+6 pfuNA Reduction in tumor volume to below 1.5 cubic centimeter after 22 days compared to control 7.5 cubic centimeterIntravenousActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4366AlphavirusM1RNATogaviridaeNoneNoVirus in combination with 8-CPT-cAMP (20mg/kg/day)NoNANANANANANANANABALB/c nude mice subcutaneous xenograft for Capan-1 (1.0E+7)3.0E+7 pfuNA Reduction in tumor volume to below 0.2 cubic centimeter after 22 days compared to control 0.8 cubic centimeterIntravenousActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4603AdenovirusCD55-MnSODDNAAdenoviridaevirus containing MnSOD geneYesNoNoNANANANANANANANABALB/c mice xenograft for A549 cell (5.0E+6)5.0E+8 pfuNA Tumor volume reduced to 300 cubic mm comapred to control 700 cubic mm after 40 daysIntratumoralVirus induced apoptosisNANA27080225
OV_4604AdenovirusCD55-TRAILDNAAdenoviridaevirus containing TRAIL geneYesNoNoNANANANANANANANABALB/c mice xenograft for A549 cell (5.0E+6)5.0E+8 pfuNA Tumor volume reduced to 220 cubic mm comapred to control 700 cubic mm after 40 daysIntratumoralVirus induced apoptosisNANA27080225
OV_4605AdenovirusCD55-TRAIL+ CD55-MnSODDNAAdenoviridaevirus containing TRAIl and MnSOD geneYesNoNoNANANANANANANANABALB/c mice xenograft for A549 cell (5.0E+6)5.0E+8 pfuNA Tumor volume reduced to 200 cubic mm comapred to control 700 cubic mm after 40 daysIntratumoralVirus induced apoptosisNANA27080225
OV_4606AdenovirusCD55-TRAIL-IETD-MnSODDNAAdenoviridaeVirus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage siteYesNoNoNANANANANANANANABALB/c mice xenograft for A549 cell (5.0E+6)5.0E+8 pfuNA Tumor volume reduced to below 100 cubic mm comapred to control 700 cubic mm after 40 daysIntratumoralVirus induced apoptosisNANA27080225
OV_5223Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoNANANANANANANANABALB/c nude mice xenograft for H1299 (2.0E+6 cells)1.0E+7 pfuNA No significant reduction in tumor volume compared to controlIntratumoralNANANA27760834
OV_5224AdenovirusTRAD-shLucDNAAdenoviridaeVirus having shorthairpin RNA for Luciferase gene knockoutYesNoNoNANANANANANANANABALB/c nude mice xenograft for H1299 (2.0E+6 cells)1.0E+7 pfuNA No significant reduction in tumor volume compared to controlIntratumoralNANANA27760834
OV_5225AdenovirusTRAD-shDICERDNAAdenoviridaeVirus having shorthairpin RNA for DICERYesNoNoNANANANANANANANABALB/c nude mice xenograft for H1299 (2.0E+6 cells)1.0E+7 pfuNA Reduction in tumor volume to 1000 cubic mm after 35 days compared to control 6000 cubic mmIntratumoralNANANA27760834
OV_5226Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoNANANANANANANANABALB/c nude mice xenograft for SKOV3 (2.0E+6 cells)1.0E+7 pfuNA Reduction in tumor volume to 2500 cubic mm after 45 days compared to control 3500 cubic mmIntratumoralNANANA27760834
OV_5227AdenovirusTRAD-shLucDNAAdenoviridaeVirus having shorthairpin RNA for Luciferase gene knockoutYesNoNoNANANANANANANANABALB/c nude mice xenograft for SKOV3 (2.0E+6 cells)1.0E+7 pfuNA Reduction in tumor volume to 2500 cubic mm after 45 days compared to control 3500 cubic mmIntratumoralNANANA27760834
OV_5228AdenovirusTRAD-shDICERDNAAdenoviridaeVirus having shorthairpin RNA for DICERYesNoNoNANANANANANANANABALB/c nude mice xenograft for SKOV3 (2.0E+6 cells)1.0E+7 pfuNA Reduction in tumor volume to 800 cubic mm after 45 days compared to control 3500 cubic mmIntratumoralNANANA27760834
OV_5229Paroviruswild typeDNAParoviridaeNoneYesNoNoATCCNANANANANANANABALB/c nude mice xenograft for 4T1 (1.0E+5 cells)NANA Reduction in tumor volume 700 cubic mm compared to control 1700 cubic mm after 33 daysIntratumoralInduction of apoptosisIncrease production of IFN-gama and IL-2NA27776794
OV_5230Paroviruswild typeDNAParoviridaeNoneYesNoNoATCCNANANANANANANABALB/c nude mice xenograft for 4T1 (1.0E+5 cells)NANA Reduction in tumor volume 4200 cubic mm compared to control 1700 cubic mm after 33 daysIntratumoralInduction of apoptosisIncrease production of IFN-gama and IL-2NA27776794
OV_5332AdenovirusZD55-IL18DNAAdenoviridaevirus having insertion of IL18 geneNoVirus in combination with DTIC 100 microgram per mlVirus expressing IL18 geneNANANANANANANANABALB/c nude mice xenograft for A375 (2.0E+6)10 MOINA Reduction in tumor volume to 250 cubic mm after six week compared to control 800 cubic mmNAVirus induced apoptosis as measured by TUNEL assayNANA27895465
OV_5333Herpes simplex virusHSV2DNAHerpesviridaeDeletion mutant for ICP34.5 and ICP47 gene and insertion of GMCSFYesNoVirus expressing GMCSF geneNANANANANANANANABALB/c nude mice xenograft for CT26 (5.0E+5)5.0E+6 pfuNA Reduction in tumor volume 1200 cubic mm compared to control 2500 cubic mm after 28 daysIntratumoralVirus induced apoptosis as measured by TUNEL assayInduce prolifration of tumor specific T cellNA28223815
OV_5357AdenovirusYDC002DNAAdenoviridaeVirus having insertion mutant for relaxin geneYesNoNoNANANANANANANANABALB/c nude mice xenograft for 3.0E+5 MIAPaCa22.0E+6 pfuNA Reduction in tumor volume to 1700 cubic mm after 60 days compared to 2700 cubic mmIntratumoralVirus induced apoptosisNANA28315430
OV_5358AdenovirusYDC002DNAAdenoviridaeVirus having insertion mutant for relaxin geneYesNoNoNANANANANANANANABALB/c nude mice xenograft for 5.0E+5 BxPC32.0E+6 pfuNA Reduction in tumor volume to 1000 cubic mm after 60 days compared to 2700 cubic mmIntratumoralVirus induced apoptosisNANA28315430
OV_5359AdenovirusYDC002DNAAdenoviridaeVirus having insertion mutant for relaxin geneYesNoNoNANANANANANANANABALB/c nude mice xenograft for 5.0E+5 PANC12.0E+6 pfuNA Reduction in tumor volume to 400 cubic mm after 60 days compared to 1000 cubic mmIntratumoralVirus induced apoptosisNANA28315430
OV_5360AdenovirusYDC002DNAAdenoviridaeVirus having insertion mutant for relaxin geneNoVirus in combination with Gemcitabine 1.5mg/kgNoNANANANANANANANABALB/c nude mice xenograft for 3.0E+5 MIAPaCa22.0E+6 pfuNA Reduction in tumor volume to 500 cubic mm after 60 days compared to 2700 cubic mmIntratumoralVirus induced apoptosisNANA28315430
OV_5361AdenovirusYDC002DNAAdenoviridaeVirus having insertion mutant for relaxin geneNoVirus in combination with Gemcitabine 1.5mg/kgNoNANANANANANANANABALB/c nude mice xenograft for 5.0E+5 BxPC32.0E+6 pfuNA Reduction in tumor volume to 400 cubic mm after 60 days compared to 2700 cubic mmIntratumoralVirus induced apoptosisNANA28315430
OV_5362AdenovirusYDC002DNAAdenoviridaeVirus having insertion mutant for relaxin geneNoVirus in combination with Gemcitabine 1.5mg/kgNoNANANANANANANANABALB/c nude mice xenograft for 5.0E+5 PANC12.0E+6 pfuNA Reduction in tumor volume to 100 cubic mm after 60 days compared to 1000 cubic mmIntratumoralVirus induced apoptosisNANA28315430
OV_5368Herpes simplex virusHF10DNAHerpesviridaeNoneYesNoNoNANANANANANANANABALB/c mice isograft for 1.0E+6 MC26 cells1.0E+7 pfu on day 10, 17 and 24NA Reduction in tumor volume to 500 mm compared to control 2500 mm after 28 days and increase in survival timeSubcutaneousNAStimulation of cytotoxic CD8 T cellsNA28331843
OV_5381Maraba virusMG1RNARhabdoviridaeNoneYesNoNoNANANANANANANANABALB/c mice isograft for 2.0E+5 4T1 cellsNoNA Reduction in tumor volume to 400 cubic mm compared to control 800 cubic mm after 25 days and increase in survival time to 45 days compared to 40 days controlIntratumoralInduction of apoptosisLevel of IFN beta production does not effected by combinationIn clinical trial for various cancer cell line27503504
OV_5382Maraba virusMG1RNARhabdoviridaeNoneYesNoNoNANANANANANANANABALB/c mice isograft for 2.0E+5 EMT6 cellsNoNA Reduction in tumor volume to 800 cubic mm compared to control 1000 cubic mm after 18 days and increase in survival time to 30 days compared to 25 days controlIntratumoralInduction of apoptosisLevel of IFN beta production does not effected by combinationIn clinical trial for various cancer cell line27503504
OV_5384Maraba virusMG1RNARhabdoviridaeNoneNoVirus in combination with 2mg/kg micromolar palcitaxel for 48 hoursNoNANANANANANANANABALB/c mice isograft for 2.0E+5 4T1 cellsNoNA Reduction in tumor volume to 200 cubic mm compared to control 800 cubic mm after 25 days and increase in survival time to 60 days compared to 40 days controlIntratumoralInduction of apoptosisLevel of IFN beta production does not effected by combinationIn clinical trial for various cancer cell line27503504
OV_5385Maraba virusMG1RNARhabdoviridaeNoneNoVirus in combination with 10mg/kg micromolar palcitaxel for 48 hoursNoNANANANANANANANABALB/c mice isograft for 2.0E+5 EMT6 cellsNoNA Reduction in tumor volume to 400 cubic mm compared to control 1000 cubic mm after 18 days and increase in survival time to 30 days compared to 25 days controlIntratumoralInduction of apoptosisLevel of IFN beta production does not effected by combinationIn clinical trial for various cancer cell line27503504
OV_5457Vaccinia viruswild typeDNAPoxviridaeNoneYesNoNoNANANANANANANANABalb/c mice injected with tumor1.0E+4 pfuNA Mice failed to develop cancerSubcutaneousNANANAUS41098983
OV_5458Vaccinia viruswild typeDNAPoxviridaeNoneYesNoNoNANANANANANANANABalb/c mice injected with tumor1.0E+5 pfuNA Mice failed to develop cancerSubcutaneousNANANAUS41098983
OV_5459Vaccinia viruswild typeDNAPoxviridaeNoneYesNoNoNANANANANANANANABalb/c mice injected with tumor1.0E+6 pfuNA Mice failed to develop cancerSubcutaneousNANANAUS41098983
OV_5484Herpes simplex virusG207-1DNAHerpesviridaeDeletion mutant for gamma 34.5 and ICP6 geneYesNoNoATCCHuman glioma cell lineU-87 MGNANANANANABalb/c mice xenograft for U-87MG5.0E+7 pfuNA Reduction in tumor growth below 2%IntraneoplasticNANANAUS5585096
OV_5485Herpes simplex virusG207-2DNAHerpesviridaeDeletion mutant for gamma 34.5 and ICP6 geneYesNoNoATCCHuman glioma cell lineU-87 MGNANANANANABalb/c mice xenograft for U-87MG5.0E+7 pfuNA Reduction in tumor growth below 5%IntraneoplasticNANANAUS5585096
OV_5510Herpes simplex virusG207-1DNAHerpesviridaeDeletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductaseYesNoNoATCCHuman glioma cell lineU-87 MGNANANANANABalb/c mice xenograft for U-87MG5.0E+7 pfuNA Reduction in tumor growth below 2%IntraneoplasticNANANAUS5728379
OV_5511Herpes simplex virusG207-2DNAHerpesviridaeDeletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductaseYesNoNoATCCHuman glioma cell lineU-87 MGNANANANANABalb/c mice xenograft for U-87MG5.0E+7 pfuNA Reduction in tumor growth below 5%IntraneoplasticNANANAUS5728379
OV_5536Herpes simplex virusG207-1DNAHerpesviridaeDeletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductaseYesNoNoATCCHuman glioma cell lineU-87 MGNANANANANABalb/c mice xenograft for U-87MG5.0E+7 pfuNA Reduction in tumor growth below 2%IntraneoplasticNANANAUS6139834
OV_5537Herpes simplex virusG207-2DNAHerpesviridaeDeletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductaseYesNoNoATCCHuman glioma cell lineU-87 MGNANANANANABalb/c mice xenograft for U-87MG5.0E+7 pfuNA Reduction in tumor growth below 5%IntraneoplasticNANANAUS6139834
OV_5673AdenovirusOV802DNAAdenoviridaeNoneYesNoNoNANANANANANANANABalb/c mice xenograft for A549 (5.0E+6 )4.0E+8 pfuNA Reduction in tumor volume to below 300 after 80 daysNANAInduction of IFN-Gamma, IL6 and other immunostimulatory cytokines productionNAUS7473418
OV_5883ParovirusMutantDNAParoviridaeDeletion mutatnt for Gamma 34.5, ICP6 and ICP47 geneYesNoYesNANANANANANANANABalb/c mice xenograft for PANC-11 RU per mlNA Tumor volume reduced to 500mm after 83 daysIntratumoralNANANAUS8916176
OV_5884ParovirusMutantDNAParoviridaeDeletion mutatnt for Gamma 34.5, ICP6 and ICP47 geneYesNoYesNANANANANANANANABalb/c mice xenograft for HeLa (2.0E+6)1 RU per mlNA Survival time increased up to 40 daysIntratumoralNANANAUS8916176
OV_5914Newcastle disease virusNDV-F3aaRNAParamyxoviridaeVirus expressing NS1 proteinYesNoNoNANANANANANANANABALB/c mice xenograft for B16-F10 (1.0E+5)5.0E+6 pfuNA Complete regression in tumor volume after 25 daysIntratumoralNAVirus induced IFN-gamma productionNAUS10035984